CClinicalTrials.gg
CompletedNCT01469312Updated Nov 11, 2011

Effect of Pasta on Blood Glucose Response in Normal Subjects

An interventional study of modified pasta in Blood Glucose Concentration, Type 2 Diabetes and Metabolic Syndrome, sponsored by Minneapolis Veterans Affairs Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-11-11.

Sponsored by Minneapolis Veterans Affairs Medical Center · Not applicable and Interventional

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

The objective of this study is to determine whether ingestion of modified pasta products (Dreamfields, Miracle Noodles) result in an improvement in blood glucose concentration when compared with a traditional pasta.

Read the detailed description

On one occasion the pasta will be a traditionally available pasta; on another occasion, approximately 1 week later a modified pasta, advertised to contain \~ 5 grams of digestible carbohydrate, or to be low in digestible starch, will be studied.

02

Conditions studied

  • Blood Glucose Concentration
  • Type 2 Diabetes
  • Metabolic Syndrome

Browse trials for

Keywords

  • Low Biologically Available Glucose Diet (LoBAG diet)
  • Diabetes
  • Glycemic Index
03

In context

Metabolic Syndrome

1,964 studies on the registry are indexed under Metabolic Syndrome; 329 are open to participants now.

This study's enrollment of 20 is below the median of 60 across 1,459 interventional studies indexed under Metabolic Syndrome.

Browse Metabolic Syndrome studies →

Lead sponsor

Minneapolis Veterans Affairs Medical Center is the lead sponsor of 40 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Normal blood glucose concentration
05

Study design

Phase
Not applicable
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
20 participants (actual)

Study arms

  • Placebo comparator
    Control

    The control arm consists of the traditional pasta.

    Other: modified pasta

  • Active comparator
    Modified pasta

    Dreamfields, Miracle Noodles

    Other: modified pasta

Interventions

  • Othermodified pasta

    50 grams carbohydrate as a single breakfast meal

    Also known as: Dreamfields Pasta, Miracle Noodles

06

What researchers measure

Primary outcomes

  1. Change in Blood Glucose

    Blood glucose will be determined by finger stick.

    Time frame: 0, 30, 60, 90, 120, and 180 minutes after ingestion

07

Study locations

1 site
  • Minneapolis VA Health Care System
    Minneapolis, Minnesota 55417, United States
08

References and documents

Publications

  • Nuttall FQ, Schweim K, Hoover H, Gannon MC. Effect of the LoBAG30 diet on blood glucose control in people with type 2 diabetes. Br J Nutr. 2008 Mar;99(3):511-9. doi: 10.1017/S0007114507819155. Epub 2007 Sep 10. PubMed 17868489 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 11, 2011, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01469312
Lead sponsor
Minneapolis Veterans Affairs Medical Center
Responsible party
Frank Q. Nuttall, MD, PhD (Chief, Section of Endocrinology, Metabolism & Nutrition, Professor of Medicine, Minneapolis Veterans Affairs Medical Center) — Principal investigator
First posted
Nov 10, 2011
Start date
Apr 2010
Primary completion
Oct 2011
Completion
Oct 2011
Last update
Nov 11, 2011

Study contacts

Frank Q Nuttall, M.D., Ph.D.
principal investigator · Minneapolis Veterans Affairs Medical Center
Mary C Gannon, Ph.D.
principal investigator · Minneapolis Veterans Affairs Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion